Impact Factor
3.15
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.47
177 total citations
h5-index
23
h5 depth signal
Cited share
75.3%
58 of 77
Total citations
177
Citation footprint
Metric signal
2.49
External metric anchor
Self-citation
7.3%
13 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
153
United States
87
Canada
32
Italy
32
Sweden
31
Citing Fields of Research
Breast Cancer
143
Oncology
108
Liver & Colon Cancer
91
Lung Cancer
29
Clinical Laboratory Science
24
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,672
Articles tracked across the journal lifetime
Indexed publication set
77
58 cited publications
Last 12 months
45
3.8 publications/month
Open access share
31.1%
14 OA publications in the last year
Leading citing country
United Kingdom
153 citing publications
Leading citing field
Breast Cancer
143 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Jan. 1994-
v1n1,Jan. 1994-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Liver & Colon Cancer
Lung Cancer
Issuing & Sponsoring Bodies
Contributor
Medical Screening Society
Broad Categories
Epidemiology
Public Health
Breast Cancer
Liver & Colon Cancer
Oncology
Lung Cancer
MeSH Descriptors
Diagnostic Tests, Routine
Mass Screening
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/09691413261498648
Open DOI
Factors associated with cytology triage attendance after a hrHPV-positive self-sample and age-related differences: The lifelines cohort
Background: Self-sampling for high-risk human papillomavirus (hrHPV) testing has been introduced in cervical cancer screening programs to improve participation. In the Netherlands, women with an hrHPV-positive self-sample are required to...
02
DOI 10.1177/09691413261498649
Open DOI
The association between the impact of cancer screening on early-stage cancers and on cancer mortality: A systematic review and meta-analysis
Background: Cancer-specific mortality traditionally has been used to evaluate the effectiveness of cancer screening, and reduction of late-stage disease has been found to correlate with reduction of cancer-specific mortality, but measure...
03
DOI 10.1177/09691413261494999
Open DOI
Breast cancer overdiagnosis due to mammography screening—A long-term follow-up population study of BreastScreen Norway
Objectives: Estimates of breast cancer overdiagnosis related to mammography screening vary substantially. Overdiagnosis is commonly defined as cases that would not have been detected during the person's remaining lifetime in the absence ...
04
DOI 10.1177/09691413261495461
Open DOI
Disparities in participation in the Finnish cervical cancer screening programme: The role of birth country, education level and age
Objective: To examine participation in organised cervical cancer screening in Finland by age, country of birth, education and area of residence. Methods: This population-based register study included all women aged 25–69 invited to organ...
05
DOI 10.1177/09691413261494817
Open DOI
Mammogram utilization among women with vision and/or hearing loss: Insights from the 2022 Behavioral Risk Factor Surveillance Survey
Purpose: Persons with sensory loss face significant barriers when accessing healthcare services, specifically screening for breast cancer. The U.S. Centers for Disease Control and Prevention recommend that women aged 40–74 get screened f...
06
DOI 10.1177/09691413261484526
Open DOI
Socioeconomic inequalities in cervical cancer screening coverage in England
Higher mortality from cervical cancer and lower cervical screening attendance in England are both associated with social deprivation. Linkage of 2012 data showed 4.9% percentage points between coverage in the upper and lower quintile of ...
07
DOI 10.1177/09691413261481721
Open DOI
Risk-based lung cancer screening with low-dose computed tomography in a Canadian province: Evaluation results of a demonstration project in Quebec, Canada
Background: A Lung Cancer Screening Demonstration Project using low-dose computed tomography (LDCT) was launched in Quebec, Canada to inform province-wide lung cancer screening implementation. This study analyses key performance indicato...
08
DOI 10.1177/09691413261486810
Open DOI
Impact of screening programs on the prenatal diagnosis (detection rate) of trisomy 13 and 18 over a 30-year period
Objective: To evaluate the impact of screening policies in Tuscany on the detection of trisomy 13 and trisomy 18 (T13/T18) with respect to time of diagnosis. A secondary aim was to evaluate the prevalence of these aneuploidies and to rep...
09
DOI 10.1177/09691413261478764
Open DOI
A natural history model of oesophageal adenocarcinoma to inform power calculations for the BEST4 screening trial
Objective: Oesophageal adenocarcinoma (OAC) has a poor prognosis, often due to its late stage at diagnosis. Individuals diagnosed with Barrett's oesophagus (BO), a precursor condition to OAC, are offered surveillance with the goal of ide...
10
DOI 10.1177/09691413261479224
Open DOI
Increasing lung cancer screening referral/order and completion rates in primary care through patient outreach and shared decision making
Objective: This study tested methods to increase lung cancer screening referral/order and completion rates in primary care. Methods: Patients identified via the electronic medical record as potentially lung cancer screening eligible were...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Vols. for 2003- issued by: Medical Screening Society.
Vol. 1, no. 1 (JAN 1994)19951129 Notice not published Printed on acid-free paper